351 related articles for article (PubMed ID: 4703827)
1. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
Cooper BR; Breese GR; Grant LD; Howard JL
J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
[No Abstract] [Full Text] [Related]
2. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
Stricker EM; Zigmond MJ
J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
[No Abstract] [Full Text] [Related]
3. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
Smith RD; Cooper BR; Breese GR
J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
[No Abstract] [Full Text] [Related]
4. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
Rech RH; Carr LA; Moore KE
J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
[No Abstract] [Full Text] [Related]
5. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
Hollister AS; Breese GR; Cooper BR
Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
[No Abstract] [Full Text] [Related]
6. Serotonin and behavior: a brief summary.
Aprison MH; Hingtgen JN
Fed Proc; 1972; 31(1):121-9. PubMed ID: 4333248
[No Abstract] [Full Text] [Related]
7. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
Lenard LG; Beer B
Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
[TBL] [Abstract][Full Text] [Related]
8. Some actions of pentazocine on behavior and brain monoamines in the rat.
Holtzman SG; Jewett RE
J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
[No Abstract] [Full Text] [Related]
9. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ
Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512
[No Abstract] [Full Text] [Related]
10. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
Cooper BR; Breese GR; Howard JL; Grant LD
Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
[No Abstract] [Full Text] [Related]
11. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Cooper BR; Breese GR
Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
[No Abstract] [Full Text] [Related]
12. Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze.
Howard JL; Grant LD; Breese GR
J Comp Physiol Psychol; 1974 Jun; 86(6):995-1007. PubMed ID: 4836849
[No Abstract] [Full Text] [Related]
13. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
Sorenson CA; Vayer JS; Goldberg CS
Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
[No Abstract] [Full Text] [Related]
14. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
Bloom FE; Aghajanian GK
J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
[No Abstract] [Full Text] [Related]
15. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
Uretsky NJ; Seiden LS
J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
[No Abstract] [Full Text] [Related]
16. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
Ahlenius S
Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
[No Abstract] [Full Text] [Related]
17. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
Zigmond MJ; Stricker EM
Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
[No Abstract] [Full Text] [Related]
18. Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine.
Breese GR; Smith RD; Cooper BR; Grant LD
Pharmacol Biochem Behav; 1973; 1(3):319-28. PubMed ID: 4775860
[No Abstract] [Full Text] [Related]
19. Mechanism of central action of octopamine.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
Fulton SC; Healy MD
Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
